The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions

Journal of Pathology

Volumn 184, Issue 1, 1998, Pages 89-95

  Goebeler, Matthias ^a   Toksoy, Atiye ^a   Spandau, Ullrich ^a   Engelhardt, Eva ^a   Bröcker, Eva Bettina ^a   Gillitzer, Reinhard ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Chemokines; Chemotaxis; Mig; Psoriasis; T cells

Indexed keywords

CHEMOKINE; RANTES;

ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MACROPHAGE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CHEMOKINES; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MACROPHAGES; PSORIASIS; RNA, MESSENGER; SKIN; T-LYMPHOCYTES;

EID: 0031908882     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO;2-Z     Document Type: Article

References (26)

1. Gillitzer R, Berger R, Mielke V, Müller C, Wolff K, Stingl G. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 1991; 97: 73-79.
2. Gillitzer, R, Ritter U, Spandau U, Goebeler M, Bröcker EB. Differential expression of GRO-α and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996; 107: 778-782.
3. Kulke R, Tödt-Pingel I, Rademacher D, Röwert J, Schröder JM, Christophers E. Co-localized overexpression of GRO-α and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J Invest Dermatol 1996; 106: 526-530.
4. Yoshimura T, Robinson EA, Tanaka S, Appella E, Lerman MI, Leonard RJ. Purification and amino acid analysis of two glioma-derived monocyte diemoattractants. J Exp Med 1989; 169: 1449-1459.
5. Gillitzer R, Wolff K, Tong D, et al. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 1993; 101: 127-131.
6. Valdimarsson H, Baker BS, Jonsdottir I, Fry L. Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 1986; 7: 256-259.
7. Baker B, Fry L. The immunology of psoriasis. Br J Dermatol 1992; 126: 1-9.
8. Gottlieb SL, Gilleaudeau P, Johnson R, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1995; 1: 442-447.
9. Uyemara K, Ymamura M, Fiveson DF, Modlin RL, Nikoloff BJ. The cytokine network in lesional and lesional-free psoriatic skin is characterized by a T helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701-705.
10. Springer TA. Traffic signals for lymphocyte recirculation and lymphocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
11. Larson CG, Andersen AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T-lymphocytes. Science 1989; 243: 1464-1466.
12. Jinquan T, Frydenberg J, Mukaida N, et al. Recombinant human growth-regulated oncogene-a induces T lymphocyte chemotaxis. J Immunol 1995; 155: 5359-5368.
13. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994; 91: 3652-3656.
14. Wolpe SD, Davatelis G, Sherry B, et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988; 167: 570-581.
15. Sherry B, Tekamp-Olson P, Gallegos C, et al. Resolution of the two components of macrophage inflammatory protein-1, and cloning and characterization of one of those components, macrophage inflammatory protein 1β. J Exp Med 1988; 168: 2251-2259.
16. Luster AD, Ravelch JV. Biochemical characterization of a g-interferon-inducible cytokine (IP-10). J Exp Med 1987; 166: 1084-1097.
17. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-672.
18. Farber JM. HuMIG: a new human member of the chemokine family of cytokines. Biochem Biophys Res Commun 1993; 192: 223-230.
19. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. Human Mig chemokine: biochemical and functional characterization. J Exp Med 1995; 182: 1301-1314.
20. Taub DD, Lloyd AR, Conlon K, et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177: 1809-1814.
21. Schall T, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
22. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 1993; 77: 1821-1826.
23. Gillitzer R, Berger R, Moll H. A reliable method for simultaneous demonstration of two antigens using a novel combination of immunogold-silver staining and immunoenzymatic labelling. J Histochem Cytochem 1990; 38: 307-331.
24. Ritter U, Moll H, Laskay T, et al. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis 1996; 173: 699-709.
25. Sticherling M, Bornscheuer E, Schröder JM, Christophers E. Localization of neutrophil-activating peptide-1/interleukin-8 immiinoreactivity in normal and psoriatic skin. J Invest Dermatol 1991; 96: 26-30.
26. Pinkus H, Mehregan AH. The primary histologic lesion of seborrhoeic dermatitis and psoriasis. J Invest Dermatol 1996; 46: 109-116.